The EU Industrial R&D Investment Scoreboard from the European Commission’s Joint Research Centre (JRC) provides economic and financial data and analysis of the top 1,500 corporate R&D investors worldwide. The 2012 Scoreboard reveals that R&D investment is up from 2011 and that R&D investment by EU companies beats the global average. It is on par with US firms, and is far ahead of Japanese companies.
R&D Investment by the Top 1,500 Companies by World Region
Total R&D investment increased from € 456 bn in 2010 to € 511 bn in 2011. Chinese and Japanese investment showed the largest increases by 1.0 and 0.2 percentage points, respectively.
World’s Top 20 Companies by their R&D Investment in 2011
The top ten companies each invested more than € 5 bn in R&D. They account for 13.5 % of the total R&D investment by the top 1,500 companies – a similar proportion to 2010.
R&D Expenditure as a Percentage of Sales in 2011
Chemical companies’ R&D investment remained similar to 2010.
R&D Ranking of Industrial Sectors and Shares of World Regions
for the Top 1,500 Companies
High-tech Industries’ Growth Between 2002–2011
Firms within the Pharmaceutical and Biotechnology sector showed the highest average sales growth (23.7 %).
[1] The 2012 EU Industrial R&D Investment Scoreboard, European Commission’s Joint Research Centre (JRC), Brussels, Belgium.
[2] Facts and Figures 2012, European Chemical Industry Council (Cefic), Brussels, Belgium.
[3] Top 100 Chemical Companies, ICIS Chemical Business Magazine, 2012, September.
[4] Annual Pharma Exec 50, J. Cacciotti, P. Clinton, Pharmaceutical Executive, 2012, May.
Also of interest:
